Expected AF prevalent population (mean (SD)) | 3996.0 (103.0) | 4143.3 (98.4) | 4316.1 (100.3) | 4478.3 (104.8) | 4617.7 (105.7) | 4757.2 (105.3) | 4911.6 (116.4) | 5014.4 (132.5) |
Measure 1: Admission with stroke as primary diagnosis | | |
Incidence (mean (SD)) | 33.5 (5.9) | 32.3 (4.67) | 33.6 (3.7) | 36.2 (6.7) | 35.8 (6.2) | 35.1 (4.9) | 42 (5.6) | 37.4 (5.2) |
Sex (n (%)) | | | | | | | | |
Male | 17.3 (51.5) | 19.3 (59.7) | 16.0 (47.6) | 20.8 (57.4) | 21.5 (60) | 21.3 (60.6) | 23.8 (56.7) | 20 (54.8) |
Female | 16.3 (48.5) | 13.0 (40.3) | 17.6 (52.4) | 15.4 (42.6) | 14.3 (40) | 13.8 (39.4) | 18.2 (43.3) | 16.9 (45.2) |
Age group (n (%)) | | | | | | | | |
0–17 | 0.2 (0.5) | 0.1 (0.3) | 0.2 (0.5) | 0.8 (2.3) | 0.4 (1.2) | 0.1 (0.2) | 0.1 (0.2) | 0.0 (0.0) |
18–64 | 10.0 (29.9) | 8.5 (26.3) | 8.3 (24.6) | 9.3 (25.6) | 11.1 (30.9) | 11.3 (32.3) | 14.0 (33.3) | 10.4 (27.8) |
>65 | 23.3 (69.7) | 23.7 (73.4) | 25.2 (74.9) | 26.1 (72.1) | 24.3 (67.9) | 23.7 (67.5) | 27.9 (66.5) | 27.0 (72.2) |
Standardised rate (per 100 000) (mean (SD)) | 797.3 (179.2) | 776.2 (115.9) | 762.0 (79.2) | 786.1 (154.1) | 729.5 (190.6) | 739.2 (96.6) | 858.9 (110.1) | 747.7 (87.7) |
Measure 2: Admission with stroke as primary diagnosis and AF as secondary diagnosis | |
Incidence (mean (SD)) | 7.7 (0.5) | 7.5 (0.7) | 9.3 (0.6) | 8.7 (1.9) | 7.8 (2.2) | 6.4 (0.8) | 8.4 (0.6) | 8.5 (0.7) |
Sex (n (%)) | | | | | | | | |
Male | 2.9 (38.0) | 4.0 (53.3) | 4.0 (43.2) | 4.4 (51.0) | 3.8 (48.4) | 3.4 (53.3) | 5.0 (59.4) | 4.0 (47.1) |
Female | 4.8 (62.0) | 3.5 (46.7) | 5.3 (56.8) | 4.3 (49.0) | 4.0 (51.6) | 3.0 (46.8) | 3.4 (40.6) | 4.5 (52.9) |
Age group (n (%)) | | | | | | | | |
0–17 | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) |
18–64 | 0.4 (5.4) | 1.2 (15.6) | 0.9 (9.9) | 0.9 (10.6) | 0.9 (11.8) | 0.8 (13.0) | 1.5 (17.8) | 1.8 (21.6) |
>65 | 7.3 (94.6) | 6.3 (84.4) | 8.3 (90.1) | 7.8 (89.4) | 6.8 (88.2) | 5.6 (87.0) | 6.9 (82.2) | 6.7 (78.4) |
Standardised rate (per 100 000) (mean (SD)) | 32.1 (2.4) | 30.1 (2.7) | 35.8 (2.3) | 32.3 (7.2) | 28.2 (8.4) | 22.6 (2.8) | 28.7 (1.9) | 29.0 (2.3) |
Measure 3: Admission with bleeding as primary diagnosis and AF in any position of diagnosis | |
Incidence (mean (SD)) | 3.25 (0.4) | 2.7 (0.9) | 3.8 (0.5) | 3.6 (0.1) | 3.4 (0.8) | 4.7 (0.3) | 6.3 (0.9) | 4.8 (0.2) |
Sex (n (%)) | | | | | | | | |
Male | 1.8 (56.4) | 1.2 (43.8) | 2.2 (56.5) | 2.3 (62.8) | 2.1 (61.0) | 2.9 (62.5) | 4.3 (67.1) | 3.0 (62.1) |
Female | 1.4 (43.6) | 1.5 (56.3) | 1.7 (43.5) | 1.3 (37.2) | 1.3 (39.0) | 1.8 (37.5) | 2.1 (32.9) | 1.8 (37.9) |
Age group (n (%)) | | | | | | | | |
0–17 | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) |
18–64 | 0.3 (10.3) | 0.2 (6.3) | 0.3 (6.5) | 0.1 (2.3) | 0.1 (2.4) | 0.3 (7.1) | 0.5 (7.9) | 0.2 (3.4) |
>65 | 2.9 (89.7) | 2.5 (93.8) | 3.6 (93.5) | 3.5 (97.7) | 3.3 (97.6) | 4.3 (92.9) | 5.8 (92.1) | 4.7 (96.6) |
Standardised rate (per 100 000) (mean (SD)) | 13.6 (1.3) | 10.7 (3.9) | 14.8 (1.9) | 13.2 (0.5) | 12.3 (3.0) | 16.3 (0.1) | 21.3 (3.0) | 16.0 (1.5) |
Measure 4: Admission with bleeding as primary diagnosis and use of OAC as secondary diagnosis | |
Incidence (mean (SD)) | 2.2 (0.5) | 1.0 (0.2) | 2.8 (0.4) | 2.8 (0.7) | 3.3 (0.4) | 2.9 (0.4) | 5.3 (0.4) | 4.7 (0.5) |
Sex (n (%)) | | | | | | | | |
Male | 1.3 (57.7) | 0.4 (41.7) | 1.9 (67.6) | 1.8 (64.7) | 1.9 (59.0) | 1.3 (45.7) | 3.6 (68.3) | 3.5 (75.0) |
Female | 0.9 (42.3) | 0.6 (58.3) | 0.9 (32.4) | 1.0 (35.3) | 1.3 (41.0) | 1.6 (54.3) | 1.7 (31.8) | 1.2 (25.0) |
Age group (n (%)) | | | | | | | | |
0–17 | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.2 (3.6) |
18–64 | 0.2 (7.7) | 0.1 (8.3) | 0.4 (14.7) | 0.5 (17.6) | 0.3 (10.3) | 0.2 (5.7) | 0.8 (14.3) | 0.5 (10.7) |
>65 | 2 (92.3) | 0.9 (91.7) | 2.4 (85.3) | 2.3 (82.4) | 2.9 (89.7) | 2.8 (94.3) | 4.5 (85.7) | 4.0 (85.7) |
Standardised rate (per 100 000) (mean (SD)) | 9.1 (0.1) | 4.0 (1.0) | 10.9 (0.0) | 10.5 (2.7) | 11.7 (1.4) | 10.3 (1.3) | 17.6 (1.1) | 14.7 (0.9) |